All Locations

Top Companies in Switzerland

249 companies based in Switzerland, sorted by total funding raised.

Ecorobotix

AI-driven precision agriculture robotics

Yverdon-les-Bains, Switzerland201–500Artificial Intelligence, Climate Tech
Series D·$205.3M·Oct 2025
CRISPR Therapeutics AG Common SharesIPO

Gene editing company using CRISPR/Cas9 technology to develop transformative medicines for serious...

Zug, Switzerland201–500Biotech, Healthcare
Corporate Round·$194.0M·Sep 2016
Polkadot

Polkadot is a multichain blockchain protocol enabling interoperability between independent blockc...

Zug, Switzerland51–200Crypto & Web3
Venture Round·$193.1M·Jul 2020
GlycoEra

Selective glycan-remodeling for enhanced antibody therapy

Wädenswil, Switzerland11–50Biotech, Healthcare
Series B·$179.0M·May 2025
Alentis Therapeutics

Clinical-stage biotech developing anti‑Claudin-1 ADCs and antibodies for cancer and organ fibrosis.

Basel, Switzerland51–200Biotech, Drug Discovery
Series C·$172.0M·Apr 2023
SportradarIPO

Sportradar is a leading global sports technology company providing data, content, and integrity s...

St. Gallen, Switzerland1001–5000analytics, sports data
Private Equity·$159.0M·Sep 2021
Addex TherapeuticsIPO

Addex Therapeutics is a biopharmaceutical company focused on the development of novel, orally ava...

Plan-les-Ouates, Switzerland11–50Biopharmaceutical, Biotech
Extension Round·$155.9M·Aug 2022
BoardAcquired

Enterprise planning platform combining business intelligence, corporate performance management, a...

Chiasso, Switzerland201–500Business Intelligence, Data & Analytics
Series A·$153.8M·Jun 2026
B
Bancor/BNT

Decentralized finance protocol enabling on-chain trading and automated liquidity; creators of the...

Zug, Switzerland11–50Crypto & Web3, Fintech
Equity Crowdfunding·$152.3M·Jun 2017
21.co

Parent company of 21Shares, the world's largest provider of crypto exchange-traded products (ETPs).

Zurich, Switzerland51–200Crypto & Web3, Fintech
Series A·$146.0M·Sep 2022
VectivBioAcquired

GLP-2 analog apraglutide for short bowel syndrome

Basel, Switzerland11–50Biotech, Healthcare
Venture Round·$145.0M·Jan 2023
CRISPRIPO

A Basel, Switzerland and Boston, MA-based biopharmaceutical company created to translate CRISPR-C...

Zug, Switzerland201–500Biotech, Healthcare
Series B·$142.0M·Jan 2016
BeOne Medicines Ltd.IPO

BeOne Medicines, formerly BeiGene, is a global oncology company committed to advancing cancer car...

Basel, Switzerland5001–10000Biotech, Healthcare
Series A·$132.5M·Jan 2013
WISeKey International Holding LtdIPO

Global cybersecurity leader providing digital identity and IoT solutions using Blockchain, AI and...

Geneva, Switzerlandenterprise software, cybersecurity
Venture Round·$122.0M·Jan 2016
ObsEvaClosed

ObsEva is a clinical stage biopharmaceutical company focusing on the development of a novel gener...

Geneva, Switzerland11–50Biotech, Reproductive Health
Venture Round·$111.0M·Sep 2020
ImmunOs Therapeutics

Swiss biotech developing novel human immunomodulatory proteins for cancer treatment, focused on i...

Basel, Switzerland11–50Biotech
Series C·$102.5M·Sep 2024
DFINITY

The DFINITY Foundation's mission is to build, promote, and maintain the Internet Computer — and b...

Zurich, Switzerland51–200Crypto & Web3, Cloud
Series C·$102.0M·Aug 2018
MindMaze

Swiss neurotechnology company developing digital therapeutics and neurorehabilitation systems for...

Lausanne, Switzerland51–200Artificial Intelligence, Healthcare
Venture Round·$100.0M·Feb 2016
Neural Concept

AI-native engineering and design software platform for simulation-driven product development.

Lausanne, Switzerland51–200Artificial Intelligence, SaaS
Growth Equity·$100.0M·Dec 2025
TherachonAcquired

Developing a novel biologic therapy for achondroplasia, the most common form of dwarfism

Basel, Switzerland11–50Biotech, Healthcare
Series B·$100.0M·Aug 2018
RhyGaze

Gene therapy company focused on ophthalmology applications, based in Basel and Philadelphia.

Basel, SwitzerlandBiotech, Healthcare
Series A·$96.0M·Jan 2025
FunPlus

FunPlus is a global mobile game developer and publisher headquartered in Switzerland, with studio...

Zug, Switzerland1001–5000
Series B·$87.0M·Mar 2014
Vvardis

Swiss biomimetic oral care company developing patented dental technologies to treat early caries ...

SwitzerlandHealthcare, Medical Devices
Growth Equity·$85.0M·Apr 2026
Frontify

Brand management platform helping organizations centralize brand guidelines, digital assets, and ...

St. Gallen, Switzerland201–500Marketing Tech, Productivity
Series C·$80.6M·Sep 2021
AC Immune SAIPO

Clinical-stage biopharmaceutical company and global leader in developing precision medicine for n...

SwitzerlandBiotech, Healthcare
Private Equity·$78.1M·Dec 2016